Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights - Top-Institutions - MDSpire

Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights

  • By

  • Xue Ren

  • Feng Shang

  • Defu Yang

  • Ying Yan

  • Ying Xu

  • April 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Medical Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology

Original Source(s)

Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights

  • by Xue Ren, Feng Shang, Defu Yang, Ying Yan, Ying Xu

  • April 22, 2026

Related Content

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report